市场调查报告书
商品编码
1354320
疼痛管理药物市场规模 - 按药物类别、适应症、疼痛类型、分销管道、全球预测Pain Management Drugs Market Size - By Drug Class, Indication, Pain Type, Distribution Channel, Global Forecast |
2023 年至 2032 年,全球疼痛管理药物市场规模预计复合年增长率为 4.5%。
製药公司扩大研发投资以创造新型疼痛管理药物和製剂以提高疗效并减少副作用将推动产业成长。举个例子,2023 年 7 月,EuroAPI 的受管制物质子公司 Francopia 投资了 7,600 万美元,用于提高其位于法国 Vertolaye 工厂的止痛活性药物成分的生产。为提高止痛药的有效性和安全性而不断进行的给药系统创新也将影响产品需求。
整个疼痛管理药物市场根据药物类别、适应症、疼痛类型、分销管道和地区进行细分。
就适应症而言,关节炎疼痛领域的疼痛管理药物产业从 2023 年到 2032 年可能会录得可观的复合年增长率。这是由于缓解和消除与关节炎相关的疼痛的需求不断增加。根据疾病预防和健康促进办公室的数据,到2040 年,受关节炎影响的成年人数量预计将增加到7,840 万人。因此,越来越多地使用疼痛管理药物来治疗关节炎疼痛,以限制不适并提高生活品质将促进市场成长。
根据分销管道,线上药局市场的市场价值预计将扩大到 2032 年。这一增长可归因于人们对线上药局的日益青睐,因为它们为人们提供便利、可及性和广泛的止痛药物。寻求缓解多种疼痛的消费者。与远距医疗服务的日益整合,使患者能够在线上咨询医疗保健提供者并获得处方,也将有助于该细分市场的扩张。
从地区来看,由于越来越重视以患者为中心的护理和神经调节技术等更高的技术进步,预计到 2032 年,亚太地区疼痛管理药物市场规模将创下显着的复合年增长率。医疗保健基础设施的不断改善以及医疗服务的普及使得该地区疼痛疾病的诊断和治疗得到了更好的发展,进一步推动了人们对疼痛管理药物的偏好。
Global Pain Management Drugs Market size is poised to record 4.5% CAGR from 2023-2032.
The scaling R&D investments by pharmaceutical companies for creating novel pain management drugs and formulations for enhanced efficacy and reduced side effects will drive the industry growth. To cite an instance, in July 2023, EuroAPI's controlled substance unit Francopia invested $76 million in a project for boosting the production of pain relief active pharmaceutical ingredients at its plant in Vertolaye, France. The growing innovations in drug delivery systems to improve the effectiveness as well as safety of pain medications will also influence the product demand.
The overall pain management drugs market is segmented based on drug class, indication, pain type, distribution channel, and region.
In terms of indication, the pain management drugs industry from the arthritic pain segment may record appreciable CAGR from 2023-2032. This is due to the rising need to alleviate and eliminate pain associated with arthritis. According to the Office of Disease Prevention and Health Promotion, the number of arthritis-affected adults is projected to rise to 78.4 million by 2040. Hence, the increasing usage of pain management drugs for arthritic pain to limit the discomfort and enhance the quality of life will add to the market growth.
On the basis of distribution channel, the market value from the online pharmacies segment is expected to expand up to 2032. The growth can be attributed to the growing preference for online pharmacies as they offer convenience, accessibility, and wide range of pain relief medications to consumers seeking relief from several types of pain. The increasing integration with telemedicine services to enable patients to consult with healthcare providers online as well as receive prescriptions will also contribute to the segment expansion.
Regionally, APAC pain management drugs market size is projected to record notable CAGR through 2032 due to the rising emphasis on patient-centric care and higher technological advancements, such as neuromodulation techniques. Increasing improvements in healthcare infrastructure as well as access to medical services has led to better diagnosis and treatment of pain conditions in the region, further driving the preference for pain management drugs.